Doctor profile · Federal record
Dr. Maha Abboud, MD FACE
Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Melrose Park, IL
- NPI 1346208956
- Accepts Medicare
- MIPS 27.9 / 100 · 2023
- 40 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
1835 N 19Th Ave, Suite 206
Melrose Park, IL 601602040
(708) 345-2211
fax (708) 345-2224 - Mailing address
-
Po Box 1053
Maywood, IL 60153
Credentials & registration
- NPI registered
- May 2006 — 20 yrs on file
- Profile last updated
- October 31, 2011
- Year of graduation
- 1986 — 40 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- Illinois #036086473
- Medicaid
- IL #036086473
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1346208956. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,774
Distinct HCPCS
7
Medicare allowed
$146,178
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 842 | 264 | $131 | |
82962 |
Blood glucose (sugar) test performed by hand-held instrument | 581 | 148 | $3 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 194 | 70 | $35 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 106 | 74 | $181 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 25 | 25 | $230 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 14 | 11 | $91 | |
95249 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin | 12 | 11 | $65 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 164. This provider delivers 11× the peer median.Open Payments
Industry payments received
All-time total
$14,089
Transactions
50
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 5 | $5,995.16 | |
| Novo Nordisk Inc | 5 | $5,318.50 | |
| Abbott Laboratories | 12 | $2,350.66 | |
| Novartis Pharmaceuticals Corporation | 9 | $188.56 | |
| Corcept Therapeutics | 15 | $152.39 | |
| Tandem Diabetes Care, Inc. | 1 | $30.79 | |
| BETA BIONICS, INC. | 1 | $23.82 | |
| Xeris Pharmaceuticals, Inc. | 1 | $15.98 | |
| Insulet Corporation | 1 | $13.42 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,750
Patients
624
Total drug cost
$668,246
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 505 | 159 | $8,027 |
| Metformin Hcl Er (Metformin Hcl) | Brand | 177 | 73 | $3,078 |
| Trulicity (Dulaglutide) | Brand | 158 | 44 | $286,377 |
| Ozempic (Semaglutide) | Brand | 152 | 49 | $242,573 |
| Metformin Hcl | Generic | 135 | 55 | $2,074 |
| Repaglinide | Generic | 104 | 37 | $7,460 |
| Jardiance (Empagliflozin) | Brand | 80 | 25 | $106,012 |
| Synthroid (Levothyroxine Sodium) | Brand | 66 | 20 | $6,577 |
| Atorvastatin Calcium | Generic | 63 | 25 | $1,054 |
| Glimepiride | Generic | 63 | 25 | $1,070 |
Hospital affiliations
Frequently asked questions
What is Dr. Maha Abboud's medical specialty?
Dr. Maha Abboud practices Endocrinology, Diabetes & Metabolism Physician in Melrose Park, IL.
Where does Dr. Maha Abboud practice?
Dr. Maha Abboud practices at 1835 N 19Th Ave, Melrose Park, IL 601602040. Office phone: 7083452211.
What is Dr. Maha Abboud's NPI?
Dr. Maha Abboud's National Provider Identifier (NPI) is 1346208956, issued by NPPES.
Does Dr. Maha Abboud accept Medicare assignment?
Yes. Dr. Maha Abboud accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Maha Abboud commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Blood glucose (sugar) test performed by hand-held instrument (HCPCS 82962); Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report (HCPCS 95251). Source: CMS Medicare Physician & Other Practitioners file.